Article
In the ophthalmic market, there is a distinctive gap between industry leaders and followers.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
ASRS 2025: Dropless vitrectomy with suprachoroidal triamcinolone-moxifloxacin
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
FDA clears path for US IDE study of Myra Vision’s titratable glaucoma therapy
(EyePod) From idea to impact: Navigating ophthalmic innovation
AI applications in cataract surgery: A surgeon’s perspective
Dialing in precision: Astigmatism management with arcuate incisions